Clinical ResearchEfficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction
Under a Creative Commons license
open access
Central Illustration
Key Words
dapagliflozin
heart failure
hospitalization
mortality
sodium glucose cotransporter 2 (SGLT2) inhibitor
Abbreviations and Acronyms
BMI
body mass index
eGFR
estimated glomerular filtration rate
HF
heart failure
HFrEF
heart failure with reduced ejection fraction
KCCQ
Kansas City Cardiomyopathy Questionnaire
LVEF
left ventricular ejection fraction
NT-proBNP
N-terminal pro–B-type natriuretic peptide
NYHA
New York Heart Association
OR
odds ratio
SBP
systolic blood pressure
SGLT2
sodium glucose cotransporter 2
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.